semaglutide for autoimmune disease Do Anti-Obesity Medications Benefit Diseases? Association between autoimmune diseases and

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management but increasingly prescribed for weight management

Statins are known to prevent hepatic steatosis and non-alcoholic steatohepatitis (NASH), but underlying mechanisms of this prevention are largely unknown

If you tolerated Tirzepatide (Zepbound/Mounjaro), Retatrutide should feel similar or perhaps slightly more noticeable

In case of CKD, the use of a GLP-1RA with proven cardiovascular benefit is only recommended in those who have not achieved individualized glycemic targets despite SGLT2i treatment, or in whom SGLT2is are contraindicated or not tolerated [6, 8]

They're also there to guide you on any necessary lifestyle changes, keeping you motivated and informed